DK3334838T3 - Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører - Google Patents

Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører Download PDF

Info

Publication number
DK3334838T3
DK3334838T3 DK16754468.3T DK16754468T DK3334838T3 DK 3334838 T3 DK3334838 T3 DK 3334838T3 DK 16754468 T DK16754468 T DK 16754468T DK 3334838 T3 DK3334838 T3 DK 3334838T3
Authority
DK
Denmark
Prior art keywords
phylogrupe
phylograph
biomarkers
quantification
members
Prior art date
Application number
DK16754468.3T
Other languages
English (en)
Inventor
Gil Librado Jesús García
Manté Xavier Aldeguer
Siles Mireia López
Medina Margarita Martínez
Original Assignee
Univ Girona
Fundacio Inst Dinvestigacio Biomedica De Girona Dr Josep Trueta
Goodgut S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Girona, Fundacio Inst Dinvestigacio Biomedica De Girona Dr Josep Trueta, Goodgut S L filed Critical Univ Girona
Application granted granted Critical
Publication of DK3334838T3 publication Critical patent/DK3334838T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16754468.3T 2015-08-11 2016-08-11 Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører DK3334838T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15382427.1A EP3130680A1 (en) 2015-08-11 2015-08-11 Method for the detection, follow up and/or classification of intestinal diseases
PCT/EP2016/069188 WO2017025617A1 (en) 2015-08-11 2016-08-11 Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers

Publications (1)

Publication Number Publication Date
DK3334838T3 true DK3334838T3 (da) 2021-11-15

Family

ID=53938288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16754468.3T DK3334838T3 (da) 2015-08-11 2016-08-11 Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører

Country Status (16)

Country Link
US (2) US11299788B2 (da)
EP (2) EP3130680A1 (da)
JP (2) JP7095210B2 (da)
KR (1) KR20180048696A (da)
CN (2) CN115976239A (da)
AU (1) AU2016306627B2 (da)
CA (1) CA2995308A1 (da)
DK (1) DK3334838T3 (da)
ES (1) ES2901465T3 (da)
HK (1) HK1257108A1 (da)
HR (1) HRP20211757T1 (da)
IL (1) IL257461B (da)
MX (1) MX2018001697A (da)
PT (1) PT3334838T (da)
SI (1) SI3334838T1 (da)
WO (1) WO2017025617A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919952A (zh) 2017-06-02 2023-04-07 古德盖特公司 用于治疗生态失调的葡萄皮
CA3084012A1 (en) * 2017-11-02 2019-05-09 Mitsubishi Chemical Corporation Intraoral examination method using information on bacterial group related to clinical indexes
WO2019115755A1 (en) * 2017-12-15 2019-06-20 Vib Vzw A new inflammation associated, low cell count enterotype
CZ2018456A3 (cs) * 2018-09-08 2020-01-02 Výzkumný ústav veterinárního lékařství, v. v. i. Způsob detekce Faecalibacterium prausnitzii pomocí metody PCR v reálném čase a sada primerů pro tento způsob detekce F. prausnitzii
US20210355546A1 (en) * 2018-11-02 2021-11-18 The Regents Of The University Of California Methods to Diagnose and Treat Cancer Using Non-Human Nucleic Acids
JP2022523596A (ja) 2019-03-13 2022-04-25 グッドガット エッセ.エッレ. 結腸直腸進行新生物、進行腺腫、及び/又は結腸直腸癌をスクリーニング、診断、及び/又はモニタリングする改善された方法
WO2023049838A1 (en) * 2021-09-23 2023-03-30 Flagship Pioneering Innovations Vi, Llc Diagnosis and treatment of diseases and conditions of the intestinal tract
CN114015761A (zh) * 2021-09-24 2022-02-08 上海交通大学医学院附属瑞金医院 粪便tyrDC基因丰度作为预测左旋多巴疗效生物标志物的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
FR2820145B1 (fr) * 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome
WO2003068788A1 (en) 2002-02-13 2003-08-21 Medimolecular Pty. Ltd. Method of isolating nucleic acids from stool samples
US7696334B1 (en) * 2002-12-05 2010-04-13 Rosetta Genomics, Ltd. Bioinformatically detectable human herpesvirus 5 regulatory gene
EP1752536A4 (en) 2004-05-11 2008-04-16 Alphagen Co Ltd POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME
US7323308B2 (en) * 2004-09-03 2008-01-29 Affymetrix, Inc. Methods of genetic analysis of E. coli
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
AU2007284651B2 (en) * 2006-08-09 2014-03-20 Institute For Systems Biology Organ-specific proteins and methods of their use
WO2011009099A1 (en) 2009-07-16 2011-01-20 The Regents Of The University Of California Metabolic biomarkers of crohn's disease
EP2486143A1 (en) * 2009-10-05 2012-08-15 AAK Patent B.V. Methods for diagnosing irritable bowel syndrome
US20110195862A1 (en) 2010-02-08 2011-08-11 Pett-Ridge Jennifer Devices, methods and systems for target detection
US20140171339A1 (en) 2011-06-06 2014-06-19 The University Of North Carolina At Chapel Hill Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
KR20150090072A (ko) * 2012-10-23 2015-08-05 카리스 라이프 사이언스 스위스 홀딩스 게엠베하 압타머 및 이의 용도
JP2016511272A (ja) 2013-03-05 2016-04-14 レイクスユニフェルシテイト フローニンゲン 炎症を抑制するためのフィーカリバクテリウム・パラウスニッチィーhtf−f(dsm26943)の使用
WO2014138999A1 (en) * 2013-03-14 2014-09-18 University Of Ottawa Methods for the diagnosis and treatment of inflammatory bowel disease
WO2014197607A1 (en) 2013-06-05 2014-12-11 The Regents Of The University Of California Detection of tick-borne diseases
EP2876167A1 (en) 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
ES2661684T3 (es) 2014-03-03 2018-04-03 Fundacio Institut D'investigació Biomèdica De Girona Dr. Josep Trueta Método para diagnosticar cáncer colorrectal a partir de una muestra de heces humanas mediante PCR cuantitativa
CN104745620A (zh) * 2015-03-03 2015-07-01 昆明理工大学 蚕豆vfpp1c基因的植物表达载体及其应用

Also Published As

Publication number Publication date
AU2016306627B2 (en) 2022-01-13
EP3334838A1 (en) 2018-06-20
ES2901465T3 (es) 2022-03-22
JP2022031644A (ja) 2022-02-22
PT3334838T (pt) 2021-11-23
JP7095210B2 (ja) 2022-07-05
HRP20211757T1 (hr) 2022-02-18
WO2017025617A1 (en) 2017-02-16
US11299788B2 (en) 2022-04-12
MX2018001697A (es) 2019-04-29
WO2017025617A8 (en) 2017-07-27
IL257461A (en) 2018-04-30
KR20180048696A (ko) 2018-05-10
SI3334838T1 (sl) 2022-01-31
EP3130680A1 (en) 2017-02-15
US20190024146A1 (en) 2019-01-24
EP3334838B1 (en) 2021-10-06
US20220307075A1 (en) 2022-09-29
HK1257108A1 (zh) 2019-10-11
CN108474037A (zh) 2018-08-31
AU2016306627A1 (en) 2018-03-15
JP2018525035A (ja) 2018-09-06
IL257461B (en) 2022-05-01
CA2995308A1 (en) 2017-02-16
CN115976239A (zh) 2023-04-18

Similar Documents

Publication Publication Date Title
DK3334838T3 (da) Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører
DK3247371T3 (da) Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil
DK3212208T3 (da) Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet
DK3271358T3 (da) Spirocykliske forbindelser som agonister af muscarin m1-receptor og/eller m4-receptor
DK3277681T3 (da) Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer
DK3159406T3 (da) Kit eller indretning til påvisning af øsufagus-cancer og fremgangsmåde til påvisning
DK3213056T3 (da) Fremgangsmåder til hurtig forberedelse af mærkede glycosylaminer og til analyse af glykosylerede biomolekyler, som giver samme baggrund
DK3370828T3 (da) Oximforbindelse som agonister af muscarin m1- og/eller m4- receptoren
DK3466934T3 (da) Sulfonamidforbindelser eller salt deraf som ribonukleotidreductase-inhibitorer til behandling af kræft
DK3397648T3 (da) Fremgangsmåde til deacetylering af biopolymerer
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3341355T3 (da) (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre og tilhørende forbindelser som gaba-aminotransferaseinaktivatorer til behandling af epilepsi, afhængighed og hepatocellulært karcinom
DK3368683T3 (da) Fremgangsmåde til kvantifikationen af pd-l1
DK3201361T3 (da) Fremgangsmåder til kvantificering af cellefrit DNA
DK3283643T3 (da) Midler til diagnosticering, forudsigelse eller monitorering af Pneumocystis pneumoni
DK3304093T3 (da) Validering af biomarkørmåling
DK3313833T3 (da) Forbindelser og anvendelse deraf som inhibitorer af n-myristoyl-transferase
DK3320099T3 (da) Membranforankret eller udskilt antistof til ekspression af lentivirale vektorer
DK3497085T3 (da) Sulfonamider som gpr40- og gpr120-agonister
DK3422936T3 (da) Apparat til prøveudtagning af en eller flere analytter
DK3380526T3 (da) Miljøvenlig fremgangsmåde til fremstilling af nanocellulose og derivater deraf
DK3170784T3 (da) Fremgangsmåde til drift af et ankerspil og ankerspil
BR112016019822A2 (pt) Determinação enzimática de hba1c
DK3172177T3 (da) Mørtelsammensætning til en indendørs belægning eller beklædning
DK3483617T3 (da) Fremgangsmåde til latensmåling